Multidisciplinary Women's Health Conference 2022
IMPORTANT BROWSER INFORMATION
This site will not work on Internet Explorer 8. Please use:
Join women’s health professionals at the Multidisciplinary Women's Health Conference 2022. This educational activity will focus on timely and practical issues involving women’s health. Topics will cover a variety of health issues that are unique to women and highlight medical conditions that may cause varying symptoms which affect women differently than men.
To successfully complete this activity, the required evaluation must be completed no later than Monday, June 20, 2022. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.
This interprofessional course is designed for physicians, physician assistants, nurse practitioners, nurses, certified nurse midwives and certified midwives.
Following completion of this activity, learners will be able to:
- Discuss the Covid-19 impact on sex and gender.
- Examine use of hormonal therapy in sexual health and healthy aging.
- Decide on the design and setup of a Breast Cancer Survivorship program.
- Evaluate the role of cosmetic procedures for aging skin.
- Analyze the symptoms and management strategies of pelvic floor dysfunction.
Any commercial/in-kind support received for this educational activity will be published and announced prior to the start of the activity.
Agenda subject to change.
Shailaja Nair, MBBS, MD, FACP is Clinical Associate Professor of Medicine at Thomas Jefferson University. She also serves as the Director of Integrated Practice Program in Women’s Health, Director of Jefferson Women's Primary and Specialty Care and the Director of Education in Women’s Health. Her areas of clinical expertise include obesity, PCOS, insulin resistance and metabolic syndrome in women’s health.
Dr. Nair has been actively involved in both student and resident education throughout her career. She has been recognized as a Castle Connolly Top Doctor from 2014 to 2022 and has received the Castle Connolly Exceptional Women in Medicine and the Philadelphia Magazine top Doctor recognition from 2017 to 2022.
Thomas Jefferson University endorses the ACCME Standards for Commercial Support: Standards to Ensure Independence in CME Activities and the policies that supplement the Standards. All planners, faculty, authors, presenters, and content reviewers are required to disclose any financial relationships with ACCME defined commercial interest entities within the past 24 months. Any conflict of interests have been mitigated prior to the educational activity.
All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the US FDA for the treatment of disease(s).
Such disclosures will be available prior to the start of the activity. Jefferson Conflict of Interest resolution process may result in changes to the program agenda.
No member of the planning committee have any financial relationships to disclose.
Shailaja Nair, MD, FACP-Course Director
Katherine Sherif, MD, FACP
Elena Applegate, RN
Sarah J. Carmody, MBA, CPTD
The following faculty have no financial relationships to disclose.
Shailaja Nair, MD
Cuckoo Choudhary, MD
Nicole Dugan, PT, DPT
Madison Force, MD
Rebecca Jackson, MD
Elizabeth Jones, MD
Mishael Khan, MD
Owen Montgomery, MD
Alana Murphy, MD
Katherine Sherif, MD
Christine Soutendijk, MD
Elena V Applegate, BSN, RN
The following faculty have financial relationships to disclose.
Maysa Abu-Khalaf, MD
Advisor: Biothera; Researcher: Hibercell, Novartis, Pfizer; Consultant: Hibercell, Pfizer
Kathryn M. Rexrode, MD
This activity does not contain information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved.
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.
It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.
In support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians: This educational activity is designated for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: This activity awards 6.0 nursing contact hours.
Other Healthcare Professionals: This educational activity is designated for 6.0 AMA PRA Category 1 Credits™. Participants should claim only the credit commensurate with the extent of their participation in the activity.
PA Patient Safety and Risk credit: This educational activity offers 1.0 credits. The following session qualifies: Oncology: Breast Cancer Survivorship and Q&A.
- 6.00 AMA PRA Category 1 Credit™
- 6.00 Attendance
- 6.00 CNE
- 1.00 Patient Safety
$55: Nurses/Other Healthcare Professionals
$55: Jefferson Physicians
$45: Jefferson Nurses/Other Healthcare Professionals
No refunds will be given after Friday, April 22, 2022. See full refund policy.
Requests for refunds must be submitted in writing and received by OCPD before Friday, April 22, 2022 . Registrants who fail to attend the conference are responsible for the entire registration fee. All refunds will be processed after the conference concludes.
Should any emergency arise, of any nature, prior to the opening conference date that would prevent its schedule opening (destruction or damage to the facility by fire, flood, storms, acts of God, etc., or declaration of any emergency by the state of Pennsylvania or the United States Government), Jefferson reserves the right to cancel or postpone the conference. In the event of cancellation or postponement, Jefferson will refund registration fees, but is not responsible for related costs or expenses to registrants, including cancellation fees assessed by hotels, airlines or travel agencies.
RECORDING AND PHOTOGRAPHY STRICTLY PROHIBITED
Unauthorized recording or photography at a Jefferson-sponsored event is strictly prohibited. Individuals found violating this policy will be removed from the online activity or asked to leave from the live activity. No credits or refund will be issued.
JEFFERSON RELEASE POLICY
Jefferson may record/livestream/photograph this activity. These images/recordings, along with your name, may be used in Jefferson publications or on the Jefferson website. If you verbally submit any questions for Q&A sessions, you are agreeing to be recorded and to have that recording available in enduring materials. Once photographed, filmed, recorded, or videotaped, you waive any right of inspection or approval to which such images/recordings may be put and Jefferson has the right to use, publish, reproduce, modify, adapt and distribute at any time in any manner or medium.
You understand that it is your right to withhold consent to this Jefferson policy or to withdraw your previous consent at any time. You further understand that, without your consent, it is not possible to process your course registration request.
JEFFERSON HIPAA POLICY
You understand that, as an attendee of this conference hosted by Thomas Jefferson University, Jefferson University Physicians and Thomas Jefferson University Hospitals, Inc. (collectively “Jefferson”), you may gain access to certain proprietary information (“Confidential Information”), including Protected Health Information (“PHI”).
You agree to maintain the confidentiality of all Confidential Information, including PHI, obtained from any source. You agree that you will take all necessary steps to protect such Confidential Information and shall not directly or indirectly disclose or use it in any manner or for any reason, other than as necessary to complete the activity.
In furtherance of the above, you agree not to take photographs, record in any manner or otherwise reproduce any such Confidential Information. You understand that any unauthorized use or disclosure of Confidential Information by the undersigned may result in possible legal action against you by Jefferson whose confidentiality is breached.